Trial record 1 of 1 for:    NCT01866826
Previous Study | Return to List | Next Study

Rifaximin for Chronic Immune Activation in People With HIV

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
University of Pittsburgh
Walter Reed Navy MMC
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01866826
First received: May 29, 2013
Last updated: July 2, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2018
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)